Showing results (41-50 of 55) with videos related to

Sort By:
Pageof 6
The Lancet. Oncology|October 14, 2011
Phase 1-2 study of docetaxel plus aflibercept in patients with recurrent ovarian, primary peritoneal, or fallopian tube cancerRobert L Coleman, Linda R Duska, Pedro T Ramirez, et al.
Journal of Magnetic Resonance Imaging : JMRI|November 20, 2018
Quantitative imaging biomarkers alliance (QIBA) recommendations for improved precision of DWI and DCE-MRI derived biomarkers in multicenter oncology trialsAmita Shukla-Dave, Nancy A Obuchowski, Thomas L Chenevert, et al.
Neuro-Oncology|March 4, 2008
Phase II trial of irinotecan and thalidomide in adults with recurrent glioblastoma multiformeVinay K Puduvalli, Pierre Giglio, Morris D Groves, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 25, 2011
Phase II study of aflibercept in recurrent malignant glioma: a North American Brain Tumor Consortium studyJohn F de Groot, Kathleen R Lamborn, Susan M Chang, et al.
Plos One|June 30, 2021
Multi-site, multi-platform comparison of MRI T1 measurement using the system phantomKathryn E Keenan, Zydrunas Gimbutas, Andrew Dienstfrey, et al.
Magnetic Resonance in Medicine|April 13, 2021
A standard system phantom for magnetic resonance imagingKarl F Stupic, Maureen Ainslie, Michael A Boss, et al.
Magnetic Resonance in Medicine|October 31, 2017
Quantitative magnetic resonance imaging phantoms: A review and the need for a system phantomKathryn E Keenan, Maureen Ainslie, Alex J Barker, et al.
Pageof 6